NEW YORK (dpa-AFX) – US standard stocks threaten further price losses on Friday. Investors were disillusioned with the still pending political agreement on another corona aid package. Even the approval of the vaccine from BioNTech and Pfizer by the American drug agency FDA, which is likely to be forthcoming within days, did not provide any positive impetus.
Three quarters of an hour before the start of trading, the broker IG estimated the Dow Jones Industrial (Dow Jones 30 Industrial) 0.52 percent in the red at 29,843 points. This would mean that the best-known American stock index would build on its recent price drops. On a weekly basis, there is a decrease of around 1.2 percent.
Most recently, the leadership of the Republican Senate majority had rejected a bipartisan proposal for a further, more than 900 billion US dollar economic stimulus package to counter the effects of the corona pandemic.
At the biotechnology company Biontech and a US partner Pfizer it was enough for price gains of 0.2 and 1.3 percent respectively. “The FDA has just informed Pfizer that they want to work towards approval,” US Secretary of Health Alex Azar told US broadcaster ABC. The FDA confirmed this information. The CDC health authority had also been informed so that delivery of the vaccine could then start quickly. The emergency approval of the FDA could come “in the next few days”. “On Monday or Tuesday next week we could see people getting vaccinated.”
The fact that Walt Disney expects a sharp increase in the number of subscribers in its streaming division by 2024 thanks to an expanded offering has caused the entertainment giant’s shares to climb by around eight percent – thus heading for a record high.
Oracle (Oracle) titles rose 1.4 percent after quarterly figures. Despite the Corona crisis, the software company was able to increase sales as expected. The net profit of the SAP (SAP SE) competitor also increased.
MetLife’s shares rose 0.2 percent. The Swiss insurer Zurich (Zurich Insurance) is expanding its business in the USA and, as expected, is taking over the property and casualty insurance lines from its US competitor MetLife./gl/jha/
–
TRADE FOREIGN EXCHANGE WITH UP TO LEVER 30 NOW
Trade forex with high leverage and small spreads. With only € 100.00 you can benefit from the effect of € 3,000 in capital.
–
76.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford the high risk of losing your money.
–
– .
